Special Announcement - Now Screening for FDA Approved Stem Cell Study
Dr. Mitchell Sheinkop has completed training and is credentialed for an FDA-approved stem cell clinical trial for knee arthritis. Our clinic is now screening patients for this trial. Contact us at 312-475-1893 for details. Click here to learn more.

My integrated medicine doctor ————— MD reported that the risks for stem cell therapy are not known yet. Could you please tell me more about how long this procedure has been being completed in the US. In addition, what is the success rate for patients using this therapy as a alternative to knee replacement surgery.


We received this inquiry as quoted from a patient who found me on the Regenexx web site. I took the liberty of removing her doctor’s name and the name of the potential patient. As those of you who are frequent readers of my Blog know, our Cellular Orthopedic interventions are increasingly supported by evidence based medicine and our research along with that of Regenexx. The latter has been involved in Regenerative Medicine for seven years and their data is the gold standard of safety in stem cells used in conjunction with FDA guidelines and close adherence to the several Practice of Medicine guidelines. While there have been reports of some complications when stem cells were used intravenous for indications that were most inappropriate outside of the United States, to the best of my knowledge and in keeping with thorough and updated scientific evidence, there are no significant adverse effects from the use of Adult, Autogenous, Concentrated, Bone Marrow derived stem cells for reconstructive orthopedic surgery, sports medicine or skeletomuscular trauma.

The next logical question is the one I am posing for the sake of argument, do stem cells work?  To date, in the care and treatment of arthritis, especially prior to end stage disease, Bone Marrow derived and concentrated mesenchymal stem cells may have a better outcome at one year than a joint replacement in over 75% of patients according to my research. Might a booster platelet concentrate increase the percent of success? I am currently reviewing that possibility and offering a platelet lysate booster to those who qualify.

What is coming down the pipeline? The basic science research at Regenexx is ongoing because of several recent philanthropic grants enabling twol PhDs to come on board and help us define the future of stem cells intervention while complying with FDA and Practice of Medicine rules and regulations. Our immediate need is to help educate, not only the patient population as to surgical alternatives that are safe, but to help with the continued education of the physicians who provide basic medical care for the population. If you want to learn more about staying active or returning to a sport, call or make an appointment


Pin It on Pinterest

Share This